Pharmacy PEBC Practice Exam

KP presents to the pharmacy with a new prescription for Drug X. The pharmacist identifies that Drug X has the potential to interact with another medication that KP is taking and contacts the prescriber. The prescriber provides rationale for using the two agents at the same time. The pharmacist and physician agree upon appropriate follow-up measures over the next several days. Which of the following statements is correct regarding documentation of the pharmacist’s encounter with the physician? The encounter:

1. Does not need to be documented, as no changes were made to the prescription and the pharmacist has determined it is appropriate to dispense the medication.

2. Should not be documented, as documentation poses the risk of increasing the prescriber’s liability if an adverse event occurs.

3. Should be documented in the patient’s pharmacy profile and the patient should be provided with a copy of the note to reduce the pharmacist’s liability.

4. Should be documented in the patient’s pharmacy profile, with a description of the monitoring plan.

The correct answer is: Should be documented in the patient’s pharmacy profile, with a description of the monitoring plan.

Documentation of the pharmacist's encounter with the physician should be done in the patient's pharmacy profile along with a description of the monitoring plan. Option A is incorrect because although no changes were made to the prescription, it is still important to document the encounter and the rationale behind the decision to dispense the medication. Option B is incorrect because documentation is an important part of patient care and can actually help decrease liability by providing a record of communication between healthcare providers. Option C is also incorrect because documentation should not be provided to the patient, but rather kept in the pharmacy's records. Option D is the correct choice because it takes into account the importance of documenting the encounter and the monitoring plan.